{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:05:42Z","timestamp":1792785942917,"version":"4.5.0"},"reference-count":185,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Research and Innovation Foundation of Cyprus","award":["EXCELLENCE\/0421\/0543"],"award-info":[{"award-number":["EXCELLENCE\/0421\/0543"]}],"id":[{"id":"https:\/\/ror.org\/00en9ce74","id-type":"ROR","asserted-by":"crossref"}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["101034403"],"award-info":[{"award-number":["101034403"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Depression is a brain disorder with systemic consequences including effects on bone health. Clinical and preclinical evidence has associated major depressive disorder (MDD) with reduced bone mineral density (BMD), increased bone resorption, and higher fracture risk, particularly in older adults and postmenopausal women. Plausible mediators include chronic stress, hypothalamic\u2013pituitary\u2013adrenal axis dysregulation, pro-inflammatory cytokines, and altered serotonergic signaling, each of which can affect bone remodeling. Classical antidepressants, particularly selective serotonin reuptake inhibitors, have been associated with adverse skeletal outcomes in human studies, while in vitro evidence indicates effects on osteoblast differentiation, mineralization, and osteoclast activity. Human biomarker studies and preclinical evidence suggest that ketamine-related compounds can modulate bone-related pathways, although these effects appear context-, dose-, exposure-, and model-dependent. Acute and repeated ketamine administration in patients with depression has been associated with changes in bone-turnover markers, including osteoprotegerin (OPG)\/receptor activator of nuclear factor kappa-B ligand (RANKL)-related, while rodent studies suggest that arketamine may attenuate stress- and ovariectomy-induced reductions in BMD and normalize the OPG\/RANKL ratio. Conversely, preclinical bone-regeneration and explant data indicate that ketamine can reduce bone-cell viability and impair bone healing under specific experimental conditions. The skeletal effects of ketamine, its enantiomers, and its metabolites, including (2R,6R)-hydroxynorketamine, remain preliminary and is limited to human biomarker studies and preclinical rodent\/in vitro models; no clinical longitudinal BMD, bone-microarchitecture, or fracture-outcome data are currently available. This review summarizes the evidence linking depression, classical, and rapid-acting antidepressant use and bone health, and identifies gaps and priorities for future investigation, including skeletal monitoring and physiotherapy-informed rehabilitation as adjunctive clinical considerations.<\/jats:p>","DOI":"10.1093\/ijnp\/pyag044","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T11:14:50Z","timestamp":1786965290000},"source":"Crossref","is-referenced-by-count":0,"title":["From depression to bone health: examining the skeletal effects of classical and rapid-acting antidepressants"],"prefix":"10.1093","volume":"29","author":[{"given":"Polymnia","family":"Louka","sequence":"first","affiliation":[{"name":"Department of Psychology, University of Cyprus , Nicosia 2109 ,","place":["Cyprus"]},{"name":"Department of Biological Sciences, University of Cyprus , Nicosia 2109 ,","place":["Cyprus"]},{"name":"Center for Applied Neuroscience, University of Cyprus , Nicosia 1057 ,","place":["Cyprus"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A","family":"Pitsillides","sequence":"additional","affiliation":[{"name":"Skeletal Biology Group, Comparative Biomedical Sciences, The Royal Veterinary College , London NW1 0TU ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morfeas","family":"Koumas","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Cyprus , Nicosia 2109 ,","place":["Cyprus"]},{"name":"Center for Applied Neuroscience, University of Cyprus , Nicosia 1057 ,","place":["Cyprus"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Papacharalambous","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, School of Sciences, European University Cyprus , Nicosia 2404 ,","place":["Cyprus"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Sophocleous","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, School of Sciences, European University Cyprus , Nicosia 2404 ,","place":["Cyprus"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1968-8648","authenticated-orcid":false,"given":"Panos","family":"Zanos","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Cyprus , Nicosia 2109 ,","place":["Cyprus"]},{"name":"Center for Applied Neuroscience, University of Cyprus , Nicosia 1057 ,","place":["Cyprus"]},{"name":"Translational Neuroscience and Behavioral Pharmacology Research Center (TRACER), University of Cyprus , Nicosia ,","place":["Cyprus"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"2026092009063211600_ref1","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1037\/bul0000102","article-title":"Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms","volume":"143","author":"Salk","year":"2017","journal-title":"Psychol Bull"},{"key":"2026092009063211600_ref2","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1111\/jnc.16097","article-title":"The role of serotonin in depression-a historical roundup and future directions","volume":"168","author":"Bremshey","year":"2024","journal-title":"J Neurochem"},{"key":"2026092009063211600_ref3","author":"WHO"},{"key":"2026092009063211600_ref4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpsychires.2019.08.002","article-title":"Changes in the global burden of depression from 1990 to 2017: findings from the Global Burden of Disease study","volume":"126","author":"Liu","year":"2020","journal-title":"J Psychiatr Res"},{"key":"2026092009063211600_ref5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/s2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","author":"GBD 2019 Mental Disorders Collaborators","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"2026092009063211600_ref6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.molmed.2025.12.003","volume":"32","journal-title":"Trends in Molecular Medicine"},{"key":"2026092009063211600_ref7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41572-023-00454-1","article-title":"Major depressive disorder","volume":"9","author":"Marx","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"2026092009063211600_ref8","doi-asserted-by":"publisher","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2022","DOI":"10.1176\/appi.books.9780890425787"},{"key":"2026092009063211600_ref9","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/s0140-6736(96)07492-2","article-title":"Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"2026092009063211600_ref10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/s2215-0366(24)00222-0","article-title":"Global Burden of Disease 2021: mental health messages","volume":"11","author":"The","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"2026092009063211600_ref11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40273-021-01019-4","article-title":"The economic burden of adults with major depressive disorder in the United States (2010 and 2018)","volume":"39","author":"Greenberg","year":"2021","journal-title":"PharmacoEconomics"},{"key":"2026092009063211600_ref12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jad.2021.09.098","article-title":"A systematic review and meta-analysis of longitudinal cohort studies comparing mental health before versus during the COVID-19 pandemic in 2020","volume":"296","author":"Robinson","year":"2022","journal-title":"J Affect Disord"},{"key":"2026092009063211600_ref13","doi-asserted-by":"publisher","first-page":"101044","DOI":"10.1016\/j.jot.2025.101044","article-title":"Brain\u2013bone axis dysregulation: biological code underlying the bidirectional association between depression and musculoskeletal disorders","volume":"56","author":"Li","year":"2026","journal-title":"J Orthop Translat"},{"key":"2026092009063211600_ref14","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2026092009063211600_ref15","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2147\/tcrm.S138000","article-title":"A comprehensive overview on osteoporosis and its risk factors","volume":"Volume 14","author":"Pouresmaeili","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"2026092009063211600_ref16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.14740\/jocmr2970w","article-title":"Gender disparities in osteoporosis","volume":"9","author":"Alswat","year":"2017","journal-title":"J Clin Med Res"},{"key":"2026092009063211600_ref17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.34171\/mjiri.34.154","article-title":"Economic burden of osteoporosis in the world: a systematic review","volume":"34","author":"Rashki Kemmak","year":"2020","journal-title":"Med J Islam Repub Iran"},{"key":"2026092009063211600_ref18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.tem.2009.05.003","article-title":"Depression as a risk factor for osteoporosis","volume":"20","author":"Cizza","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"2026092009063211600_ref19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jad.2023.10.062","article-title":"Link between depression and bone mineral density in Cooper Center Longitudinal Study: indirect effects of vitamin D, inflammation, and physical activity","volume":"344","author":"Li","year":"2024","journal-title":"J Affect Disord"},{"key":"2026092009063211600_ref20","doi-asserted-by":"publisher","first-page":"612366","DOI":"10.3389\/fpsyg.2020.612366","article-title":"Effects of neurological disorders on bone Health","volume":"11","author":"Kelly","year":"2020","journal-title":"Front Psychol"},{"key":"2026092009063211600_ref21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11657-012-0105-0","article-title":"The relationship of depression, anxiety and stress with low bone mineral density in post-menopausal women","volume":"7","author":"Erez","year":"2012","journal-title":"Arch Osteoporos"},{"key":"2026092009063211600_ref22","doi-asserted-by":"publisher","first-page":"11177","DOI":"10.1038\/s41598-022-15248-w","article-title":"The relationship between osteoporosis and depression","volume":"12","author":"Kashfi","year":"2022","journal-title":"Sci Rep"},{"key":"2026092009063211600_ref23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/s0378-5122(99)00057-2","article-title":"Depressive vulnerability is not an independent risk factor for osteoporosis in postmenopausal women","volume":"33","author":"Reginster","year":"1999","journal-title":"Maturitas"},{"key":"2026092009063211600_ref24","doi-asserted-by":"publisher","first-page":"38564","DOI":"10.52965\/001c.38564","article-title":"The use of antidepressants is linked to bone loss: a systematic review and metanalysis","volume":"14","author":"Mercurio","year":"2022","journal-title":"Orthop Rev (Pavia)"},{"key":"2026092009063211600_ref25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.afos.2017.05.002","article-title":"Serotonin reuptake inhibitors and bone health: a review of clinical studies and plausible mechanisms","volume":"3","author":"Wadhwa","year":"2017","journal-title":"Osteoporos Sarcopenia"},{"key":"2026092009063211600_ref26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA-a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res Integr Peer Rev"},{"key":"2026092009063211600_ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1192\/bjp.80.328.1","article-title":"Melancholia: a historical review: part I","volume":"80","author":"Lewis","year":"1934","journal-title":"J Ment Sci"},{"key":"2026092009063211600_ref28","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-54802-5_7","volume-title":"From Melancholia to Depression: Disordered Mood in Nineteenth-Century Psychiatry","author":"Jansson","year":"2020"},{"key":"2026092009063211600_ref29","volume-title":"Psychiatrie: Ein Lehrbuch f\u00fcr Studierende Und \u00e4rzte","author":"Kraepelin","year":"1913"},{"key":"2026092009063211600_ref30","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1056\/nejm195412162512504","article-title":"Mental depression in hypertensive patients treated for long periods with large doses of reserpine","volume":"251","author":"Freis","year":"1954","journal-title":"N Engl J Med"},{"key":"2026092009063211600_ref31","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/jama.1955.02960260006002","article-title":"Depression and anxiety occurring during Rauwolfia therapy","volume":"159","author":"Muller","year":"1955","journal-title":"JAMA"},{"key":"2026092009063211600_ref32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1161\/01.CIR.19.3.366","article-title":"Depressive reactions in hypertensive patients","volume":"19","author":"Quetsch","year":"1959","journal-title":"Circulation"},{"key":"2026092009063211600_ref33","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3181\/00379727-81-19910","article-title":"In vivo inhibition of liver and brain monoamine oxidase by 1-Isonicotinyl-2-isopropyl hydrazine","volume":"81","author":"Zeller","year":"1952","journal-title":"Proc Soc Exp Biol Med"},{"key":"2026092009063211600_ref34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/BF02174413","article-title":"Influence of isonicotinic acid hydrazide (INH) and 1-isonicotinyl-2-isopropyl hydrazide (IIH) on bacterial and mammalian enzymes","volume":"8","author":"Zeller","year":"1952","journal-title":"Experientia"},{"key":"2026092009063211600_ref35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bbr.2016.11.028","article-title":"Comparative efficacy and acceptability of electroconvulsive therapy versus repetitive transcranial magnetic stimulation for major depression: a systematic review and multiple-treatments meta-analysis","volume":"320","author":"Chen","year":"2017","journal-title":"Behav Brain Res"},{"key":"2026092009063211600_ref36","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/2041318a0","article-title":"Inhibition of uptake of TRITIATED-noradrenaline IN the intact rat BRAIN by imipramine and structurally related compounds","volume":"204","author":"Glowinski","year":"1964","journal-title":"Nature"},{"key":"2026092009063211600_ref37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1748-1716.1967.tb03626.x","article-title":"Quantitative in vitro studies on noradrenaline uptake and its inhibition by amphetamine, desipramine and chlorpromazine","volume":"70","author":"H\u00e4ggendal","year":"1967","journal-title":"Acta Physiol Scand"},{"key":"2026092009063211600_ref38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/0002-8703(82)90281-2","article-title":"Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications","volume":"103","author":"Marshall","year":"1982","journal-title":"Am Heart J"},{"key":"2026092009063211600_ref39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/a0038550","article-title":"A brief history of the development of antidepressant drugs: from monoamines to glutamate","volume":"23","author":"Hillhouse","year":"2015","journal-title":"Exp Clin Psychopharmacol"},{"key":"2026092009063211600_ref40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/jnnp.48.1.65","article-title":"Guillain-Barr\u00e9 syndrome following zimeldine treatment","volume":"48","author":"Fagius","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026092009063211600_ref41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ajp.2011.01.002","article-title":"Pharmaceutical industry and the market: The case of Prozac and other antidepressants","volume":"4","author":"Das","year":"2011","journal-title":"Asian J Psychiatr"},{"key":"2026092009063211600_ref42","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4088\/jcp.08m04629","article-title":"Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study","volume":"70","author":"Bauer","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"2026092009063211600_ref43","doi-asserted-by":"publisher","first-page":"108237","DOI":"10.1016\/j.neuropharm.2020.108237","article-title":"SNRIs achieve faster antidepressant effects than SSRIs by elevating the concentrations of dopamine in the forebrain","volume":"177","author":"Li","year":"2020","journal-title":"Neuropharmacology"},{"key":"2026092009063211600_ref44","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1017\/s1092852900019726","article-title":"SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS Spectr"},{"key":"2026092009063211600_ref45","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/978-3-030-62059-2_414","volume-title":"NeuroPsychopharmacotherapy","author":"Laux","year":"2022"},{"key":"2026092009063211600_ref46","doi-asserted-by":"publisher","first-page":"133","DOI":"10.64719\/pb.4208","article-title":"The clinical relevance of antidepressant interaction with neurotransmitter transporters and receptors","volume":"36","author":"Richelson","year":"2002","journal-title":"Psychopharmacol Bull"},{"key":"2026092009063211600_ref47","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.biopsych.2007.03.027","article-title":"Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents","volume":"62","author":"Papakostas","year":"2007","journal-title":"Biol Psychiatry"},{"key":"2026092009063211600_ref48","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.biopsych.2021.05.008","article-title":"Brain-derived neurotrophic factor Signaling in depression and antidepressant action","volume":"90","author":"Castr\u00e9n","year":"2021","journal-title":"Biol Psychiatry"},{"key":"2026092009063211600_ref49","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"2026092009063211600_ref50","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tins.2008.06.006","article-title":"The HPA axis in major depression: classical theories and new developments","volume":"31","author":"Pariante","year":"2008","journal-title":"Trends Neurosci"},{"key":"2026092009063211600_ref51","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N Engl J Med"},{"key":"2026092009063211600_ref52","first-page":"1","volume-title":"NeuroPsychopharmacotherapy","author":"Danyeli","year":"2020"},{"key":"2026092009063211600_ref53","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol Rev"},{"key":"2026092009063211600_ref54","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/hup.2475","article-title":"The use of ketamine as an antidepressant: a systematic review and meta-analysis","volume":"30","author":"Coyle","year":"2015","journal-title":"Hum Psychopharmacol"},{"key":"2026092009063211600_ref55","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4088\/JCP.09m05327blu","article-title":"Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder","volume":"71","author":"DiazGranados","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"2026092009063211600_ref56","doi-asserted-by":"publisher","first-page":"659","DOI":"10.12688\/f1000research.14344.1","article-title":"Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide","volume":"7","author":"Duman","year":"2018","journal-title":"F1000Res"},{"key":"2026092009063211600_ref57","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/s0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"2026092009063211600_ref58","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"2026092009063211600_ref59","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/s0033-3182(73)71306-2","article-title":"The use of ketamine in psychiatry","volume":"14","author":"Khorramzadeh","year":"1973","journal-title":"Psychosomatics"},{"key":"2026092009063211600_ref60","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s43440-020-00097-z","article-title":"Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials","volume":"72","author":"Kryst","year":"2020","journal-title":"Pharmacol Rep"},{"key":"2026092009063211600_ref61","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am J Psychiatry"},{"key":"2026092009063211600_ref62","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/da.22227","article-title":"Neurobiology of stress, depression, and rapid acting antidepressants: Remodeling synaptic connections","volume":"31","author":"Duman","year":"2014","journal-title":"Depress Anxiety"},{"key":"2026092009063211600_ref63","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/2045125316631267","article-title":"Ketamine enantiomers in the rapid and sustained antidepressant effects","volume":"6","author":"Muller","year":"2016","journal-title":"Ther Adv Psychopharmacol"},{"key":"2026092009063211600_ref64","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of ketamine action as an antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol Psychiatry"},{"key":"2026092009063211600_ref65","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41386-023-01629-w","article-title":"Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms","volume":"49","author":"Krystal","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"2026092009063211600_ref66","first-page":"47","article-title":"The anti-inflammatory effects of ketamine: state of the art","volume":"62","author":"Loix","year":"2011","journal-title":"Acta Anaesthesiol Belg"},{"key":"2026092009063211600_ref67","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1038\/mp.2017.109","article-title":"Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder","volume":"23","author":"Kadriu","year":"2018","journal-title":"Mol Psychiatry"},{"key":"2026092009063211600_ref68","doi-asserted-by":"publisher","first-page":"6431","DOI":"10.1038\/s41467-020-20190-4","article-title":"The role of dissociation in ketamine\u2019s antidepressant effects","volume":"11","author":"Ballard","year":"2020","journal-title":"Nat Commun"},{"key":"2026092009063211600_ref69","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/da.22505","article-title":"Ketamine for treatment-resistant unipolar and bipolar depression: critical review and implications for clinical practice","volume":"33","author":"Bobo","year":"2016","journal-title":"Depress Anxiety"},{"key":"2026092009063211600_ref70","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/0269881120959644","article-title":"Ketamine: a tale of two enantiomers","volume":"35","author":"Jelen","year":"2021","journal-title":"J Psychopharmacol"},{"key":"2026092009063211600_ref71","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0304-3959(94)00170-j","article-title":"Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain","volume":"61","author":"Mathisen","year":"1995","journal-title":"Pain"},{"key":"2026092009063211600_ref72","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","article-title":"Efficacy of Esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial","volume":"76","author":"Daly","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"2026092009063211600_ref73","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/ijnp\/pyaa068","article-title":"Esketamine nasal spray for rapid reduction of depressive symptoms in patients with major depressive disorder who have active suicide ideation with intent: results of a phase 3, double-blind, randomized Study (ASPIRE II)","volume":"24","author":"Ionescu","year":"2021","journal-title":"Int J Neuropsychopharmacol"},{"key":"2026092009063211600_ref74","doi-asserted-by":"publisher","first-page":"e632","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl Psychiatry"},{"key":"2026092009063211600_ref75","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00406-020-01110-5","article-title":"Intravenous arketamine for treatment-resistant depression: open-label pilot study","volume":"271","author":"Leal","year":"2021","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2026092009063211600_ref76","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"2026092009063211600_ref77","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/npp.2016.210","article-title":"Ketamine mechanism of action: separating the wheat from the chaff","volume":"42","author":"Gould","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"2026092009063211600_ref78","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1177\/02698811211064922","article-title":"Sex-dependent metabolism of ketamine and (2R,6R)-hydroxynorketamine in mice and humans","volume":"36","author":"Highland","year":"2022","journal-title":"J Psychopharmacol"},{"key":"2026092009063211600_ref79","doi-asserted-by":"publisher","first-page":"177604","DOI":"10.1016\/j.ejphar.2025.177604","article-title":"The antidepressant potential of (2R,6R)-hydroxynorketamine: a detailed review of pre-clinical findings","volume":"999","author":"Koutrouli","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"2026092009063211600_ref80","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/j.biopsych.2016.08.039","article-title":"Reply to: antidepressant actions of ketamine versus Hydroxynorketamine","volume":"81","author":"Zanos","year":"2017","journal-title":"Biol Psychiatry"},{"key":"2026092009063211600_ref81","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1073\/pnas.1816071116","article-title":"Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function","volume":"116","author":"Lumsden","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026092009063211600_ref82","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41386-019-0443-3","article-title":"(2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism","volume":"45","author":"Riggs","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"2026092009063211600_ref83","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-020-03047-0","article-title":"Antidepressant actions of ketamine engage cell-specific translation via eIF4E","volume":"590","author":"Aguilar-Valles","year":"2021","journal-title":"Nature"},{"key":"2026092009063211600_ref84","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1038\/mp.2017.239","article-title":"Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit","volume":"23","author":"Yao","year":"2018","journal-title":"Mol Psychiatry"},{"key":"2026092009063211600_ref85","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/B978-0-12-813259-3.00005-1","volume-title":"Basic and Applied Bone Biology (Second Edition)","author":"Allen","year":"2019"},{"key":"2026092009063211600_ref86","doi-asserted-by":"publisher","first-page":"e12740","DOI":"10.1111\/ecc.12740","article-title":"The biology of normal bone remodelling","volume":"26","author":"Katsimbri","year":"2017","journal-title":"Eur J Cancer Care (Engl)"},{"key":"2026092009063211600_ref87","doi-asserted-by":"publisher","first-page":"6910312","DOI":"10.1155\/2020\/6910312","article-title":"RANKL\/RANK\/OPG pathway: a mechanism involved in exercise-induced bone remodeling","volume":"2020","author":"Tobeiha","year":"2020","journal-title":"Biomed Res Int"},{"key":"2026092009063211600_ref88","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ar.1092260405","article-title":"Skeletal structural adaptations to mechanical usage (SATMU): 4. Mechanical influences on intact fibrous tissues","volume":"226","author":"Frost","year":"1990","journal-title":"Anat Rec"},{"key":"2026092009063211600_ref89","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.2215\/cjn.04151206","article-title":"Normal bone anatomy and physiology","volume":"3 Suppl 3","author":"Clarke","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026092009063211600_ref90","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/0004563218759371","article-title":"The bone remodelling cycle","volume":"55","author":"Kenkre","year":"2018","journal-title":"Ann Clin Biochem"},{"key":"2026092009063211600_ref91","doi-asserted-by":"publisher","first-page":"155","DOI":"10.22203\/ecm.v029a12","article-title":"Local origins impart conserved bone type-related differences in human osteoblast behaviour","volume":"29","author":"Shah","year":"2015","journal-title":"Eur Cell Mater"},{"key":"2026092009063211600_ref92","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11154-010-9153-1","article-title":"Cellular mechanisms of bone remodeling","volume":"11","author":"Eriksen","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"key":"2026092009063211600_ref93","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3390\/biology14030274","article-title":"Connecting bone remodeling and regeneration: Unraveling hormones and signaling pathways","volume":"14","author":"Mehreen","year":"2025","journal-title":"Biology (Basel)"},{"key":"2026092009063211600_ref94","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar2165","article-title":"Biology of RANK, RANKL, and osteoprotegerin","volume":"9","author":"Boyce","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"2026092009063211600_ref95","doi-asserted-by":"publisher","first-page":"125705","DOI":"10.1155\/2013\/125705","article-title":"The role of inflammatory cytokines, the RANKL\/OPG axis, and the immunoskeletal interface in physiological bone turnover and osteoporosis","volume":"2013","author":"Weitzmann","year":"2013","journal-title":"Scientifica (Cairo)"},{"key":"2026092009063211600_ref96","doi-asserted-by":"publisher","first-page":"8882429","DOI":"10.1155\/mi\/8882429","article-title":"Dual roles of prostaglandin E2 (PGE2) in bone remodeling and pain management: bridging the gap in osteoarthritis research","volume":"2025","author":"Zhang","year":"2025","journal-title":"Mediat Inflamm"},{"key":"2026092009063211600_ref97","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11657-011-0060-1","article-title":"Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","volume":"6","author":"Str\u00f6m","year":"2011","journal-title":"Arch Osteoporos"},{"key":"2026092009063211600_ref98","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1759720x16670154","article-title":"Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis","volume":"8","author":"Langdahl","year":"2016","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2026092009063211600_ref99","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s001980050224","article-title":"Interim report and recommendations of the World Health Organization task-force for osteoporosis","volume":"10","author":"Genant","year":"1999","journal-title":"Osteoporos Int"},{"key":"2026092009063211600_ref100","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1359\/jbmr.050304","article-title":"Predictive value of BMD for hip and other fractures","volume":"20","author":"Johnell","year":"2005","journal-title":"J Bone Miner Res"},{"key":"2026092009063211600_ref101","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3892\/etm.2021.10815","article-title":"Osteoporosis therapies and their mechanisms of action (review)","volume":"22","author":"Kim","year":"2021","journal-title":"Exp Ther Med"},{"key":"2026092009063211600_ref102","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/bph.15024","article-title":"Overview of treatment approaches to osteoporosis","volume":"178","author":"Langdahl","year":"2021","journal-title":"Br J Pharmacol"},{"key":"2026092009063211600_ref103","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11914-009-0004-5","article-title":"Denosumab: Anti-RANKL antibody","volume":"7","author":"Miller","year":"2009","journal-title":"Curr Osteoporos Rep"},{"key":"2026092009063211600_ref104","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fcell.2020.00325","article-title":"Pros and cons of Denosumab treatment for osteoporosis and implication for RANKL aptamer therapy","volume":"8","author":"Zhang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"2026092009063211600_ref105","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"2026092009063211600_ref106","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1038\/ncomms6215","article-title":"Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts","volume":"5","author":"Keller","year":"2014","journal-title":"Nat Commun"},{"key":"2026092009063211600_ref107","first-page":"600","article-title":"Calcitonin: a useful old friend","volume":"20","author":"Srinivasan","year":"2020","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"2026092009063211600_ref108","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/cbf.3734","article-title":"High bone mass in mice can be linked to lower osteoclast formation, resorptive capacity, and restricted in vitro sensitivity to inhibition by stable sulforaphane","volume":"40","author":"Louka","year":"2022","journal-title":"Cell Biochem Funct"},{"key":"2026092009063211600_ref109","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/cells13020165","article-title":"Stable Sulforaphane targets the early stages of osteoclast formation to engender a lasting functional blockade of Osteoclastogenesis","volume":"13","author":"Louka","year":"2024","journal-title":"Cells"},{"key":"2026092009063211600_ref110","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/molecules26020347","article-title":"Sulforaphane inhibits Osteoclastogenesis via suppression of the Autophagic pathway","volume":"26","author":"Luo","year":"2021","journal-title":"Molecules"},{"key":"2026092009063211600_ref111","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/bcp.13766","article-title":"Osteoanabolic and dual action drugs","volume":"85","author":"Tabacco","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"2026092009063211600_ref112","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/jbmr.251","article-title":"Effects of denosumab on bone turnover markers in postmenopausal osteoporosis","volume":"26","author":"Eastell","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2026092009063211600_ref113","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.mayocp.2014.11.009","article-title":"Increased risk of osteoporosis in patients with depression: a population-based retrospective cohort study","volume":"90","author":"Lee","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"2026092009063211600_ref114","doi-asserted-by":"publisher","first-page":"44","DOI":"10.6061\/clinics\/2017(01)08","article-title":"Risk of vertebral fracture in patients diagnosed with a depressive disorder: a nationwide population-based cohort Study","volume":"72","author":"Lee","year":"2017","journal-title":"Clinics (Sao Paulo)"},{"key":"2026092009063211600_ref115","doi-asserted-by":"publisher","first-page":"e00489","DOI":"10.1002\/brb3.489","article-title":"Bone density and depressive disorder: a meta-analysis","volume":"6","author":"Schweiger","year":"2016","journal-title":"Brain Behav"},{"key":"2026092009063211600_ref116","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000162297","article-title":"Depression and bone metabolism. A review","volume":"78","author":"Williams","year":"2009","journal-title":"Psychother Psychosom"},{"key":"2026092009063211600_ref117","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/00042192-200512010-00015","article-title":"Depression and bone mineral density in a community sample of perimenopausal women: Geelong Osteoporosis Study","volume":"12","author":"Jacka","year":"2005","journal-title":"Menopause"},{"key":"2026092009063211600_ref118","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1046\/j.1532-5415.2001.49149.x","article-title":"The association of bone mineral density and depression in an older population","volume":"49","author":"Robbins","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"2026092009063211600_ref119","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/PSY.0b013e3182821e91","article-title":"Bone density characteristics and major depressive disorder in adolescents","volume":"75","author":"Fazeli","year":"2013","journal-title":"Psychosom Med"},{"key":"2026092009063211600_ref120","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12916-019-1297-6","article-title":"Comparison of depression prevalence estimates in meta-analyses based on screening tools and rating scales versus diagnostic interviews: a meta-research review","volume":"17","author":"Levis","year":"2019","journal-title":"BMC Med"},{"key":"2026092009063211600_ref121","doi-asserted-by":"publisher","first-page":"8144","DOI":"10.3390\/ijerph18158144","article-title":"Anxiety levels predict bone mineral density in postmenopausal women undergoing oral bisphosphonates: a two-year follow-up","volume":"18","author":"Martino","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2026092009063211600_ref122","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/acps.13563","article-title":"Anxiety disorders are associated with reduced bone mineral density in men: findings from the Geelong Osteoporosis Study","volume":"148","author":"Roebuck","year":"2023","journal-title":"Acta Psychiatr Scand"},{"key":"2026092009063211600_ref123","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/gme.0000000000001123","article-title":"Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis","volume":"25","author":"Catalano","year":"2018","journal-title":"Menopause"},{"key":"2026092009063211600_ref124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6092\/2282-1619\/2018.6.1740","article-title":"Vitamin D status is associated with anxiety levels in postmenopausal women evaluated for osteoporosis","volume":"6","author":"Martino","year":"2018","journal-title":"Mediterr J Clin Psychol"},{"key":"2026092009063211600_ref125","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7150\/ijms.50680","article-title":"Potential mechanisms linking psychological stress to bone health","volume":"18","author":"Ng","year":"2021","journal-title":"Int J Med Sci"},{"key":"2026092009063211600_ref126","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1210\/en.2005-0717","article-title":"Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones","volume":"147","author":"Swanson","year":"2006","journal-title":"Endocrinology"},{"key":"2026092009063211600_ref127","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1172\/jci2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest"},{"key":"2026092009063211600_ref128","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1742-1241.2006.01276.x","article-title":"Relation of cortisol levels and bone mineral density among premenopausal women with major depression","volume":"61","author":"Altindag","year":"2007","journal-title":"Int J Clin Pract"},{"key":"2026092009063211600_ref129","doi-asserted-by":"publisher","first-page":"e40894","DOI":"10.1371\/journal.pone.0040894","article-title":"Do premenopausal women with major depression have low bone mineral density? A 36-month prospective study","volume":"7","author":"Cizza","year":"2012","journal-title":"PLoS One"},{"key":"2026092009063211600_ref130","doi-asserted-by":"publisher","DOI":"10.3390\/cells13050423","article-title":"Role of inflammatory mechanisms in major depressive disorder: from etiology to potential pharmacological targets","volume":"13","author":"Kouba","year":"2024","journal-title":"Cells"},{"key":"2026092009063211600_ref131","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11010-010-0674-4","article-title":"Prolactin alters the mRNA expression of osteoblast-derived osteoclastogenic factors in osteoblast-like UMR106 cells","volume":"349","author":"Wongdee","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"2026092009063211600_ref132","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2165\/11533140-000000000-00000","article-title":"Antidepressant-induced hyperprolactinaemia: incidence, mechanisms and management","volume":"24","author":"Coker","year":"2010","journal-title":"CNS Drugs"},{"key":"2026092009063211600_ref133","doi-asserted-by":"publisher","first-page":"16876","DOI":"10.1073\/pnas.0604234103","article-title":"Depression induces bone loss through stimulation of the sympathetic nervous system","volume":"103","author":"Yirmiya","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026092009063211600_ref134","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1097\/00006842-200011000-00006","article-title":"Increased bone remodeling in first-episode major depressive disorder","volume":"62","author":"Herr\u00e1n","year":"2000","journal-title":"Psychosom Med"},{"key":"2026092009063211600_ref135","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/01.psy.0000237858.76880.3d","article-title":"Bone mineral density, bone turnover, and osteoprotegerin in depressed women with and without borderline personality disorder","volume":"68","author":"Kahl","year":"2006","journal-title":"Psychosom Med"},{"key":"2026092009063211600_ref136","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11033-025-10230-x","article-title":"The underlying mechanisms of the association of bone health with depression - an experimental study","volume":"52","author":"Houtenbos","year":"2025","journal-title":"Mol Biol Rep"},{"key":"2026092009063211600_ref137","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1210\/jc.2010-0861","article-title":"Update in serotonin and bone","volume":"95","author":"Bliziotes","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2026092009063211600_ref138","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10911-023-09535-z","article-title":"The serotonergic system and bone metabolism during pregnancy and lactation and the implications of SSRI use on the maternal-offspring dyad","volume":"28","author":"Fricke","year":"2023","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2026092009063211600_ref139","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/bf01622200","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report","volume":"4","author":"Kanis","year":"1994","journal-title":"WHO Study Group Osteoporos Int"},{"key":"2026092009063211600_ref140","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1097\/01.alc.0000192039.21305.55","article-title":"Alcohol-induced bone loss and deficient bone repair","volume":"29","author":"Chakkalakal","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"2026092009063211600_ref141","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.lfs.2011.10.019","article-title":"Effects of nicotine on proliferation and osteoblast differentiation in human alveolar bone marrow-derived mesenchymal stem cells","volume":"90","author":"Kim","year":"2012","journal-title":"Life Sci"},{"key":"2026092009063211600_ref142","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1902\/jop.2003.74.10.1440","article-title":"Nicotine stimulates osteoclast resorption in a porcine marrow cell model","volume":"74","author":"Henemyre","year":"2003","journal-title":"J Periodontol"},{"key":"2026092009063211600_ref143","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol Rev"},{"key":"2026092009063211600_ref144","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1749-6632.2009.05218.x","article-title":"Depression and bone mass","volume":"1192","author":"Bab","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"2026092009063211600_ref145","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00198-015-3213-z","article-title":"Serotonergic antidepressant use and the risk of fracture: a population-based nested case-control study","volume":"27","author":"Wang","year":"2016","journal-title":"Osteoporos Int"},{"key":"2026092009063211600_ref146","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.jad.2024.10.114","article-title":"Examining depression, antidepressants use, and class and their potential associations with osteoporosis and fractures in adult women: results from ten NHANES cohorts","volume":"369","author":"Rajha","year":"2025","journal-title":"J Affect Disord"},{"key":"2026092009063211600_ref147","doi-asserted-by":"publisher","first-page":"334","DOI":"10.62641\/aep.v52i3.1560","article-title":"Osteoporosis and fracture risk associated with novel antidepressants: a systematic review and meta-analysis","volume":"52","author":"Hu","year":"2024","journal-title":"Actas Esp Psiquiatr"},{"key":"2026092009063211600_ref148","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/jcb.20734","article-title":"Serotonin and fluoxetine modulate bone cell function in vitro","volume":"98","author":"Gustafsson","year":"2006","journal-title":"J Cell Biochem"},{"key":"2026092009063211600_ref149","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.biopsych.2012.11.003","article-title":"Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function","volume":"74","author":"Hodge","year":"2013","journal-title":"Biol Psychiatry"},{"key":"2026092009063211600_ref150","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bone.2009.06.029","article-title":"The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5)","volume":"46","author":"Warden","year":"2010","journal-title":"Bone"},{"key":"2026092009063211600_ref151","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1210\/en.2004-1259","article-title":"Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth","volume":"146","author":"Warden","year":"2005","journal-title":"Endocrinology"},{"key":"2026092009063211600_ref152","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/jcb.21131","article-title":"Fluoxetine treatment increases trabecular bone formation in mice","volume":"100","author":"Battaglino","year":"2007","journal-title":"J Cell Biochem"},{"key":"2026092009063211600_ref153","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41398-022-02083-w","article-title":"Fluoxetine improves bone microarchitecture and mechanical properties in rodents undergoing chronic mild stress - an animal model of depression","volume":"12","author":"Lam","year":"2022","journal-title":"Transl Psychiatry"},{"key":"2026092009063211600_ref154","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13293-024-00587-2","article-title":"Sex differences in the effects of repeated ketamine infusions on bone markers in patients with unipolar and bipolar depression","volume":"15","author":"Lan","year":"2024","journal-title":"Biol Sex Differ"},{"key":"2026092009063211600_ref155","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jpsychires.2016.09.025","article-title":"Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression","volume":"84","author":"Park","year":"2017","journal-title":"J Psychiatr Res"},{"key":"2026092009063211600_ref156","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/ijnp\/pyy065","article-title":"Role of inflammatory bone markers in the antidepressant actions of (R)-ketamine in a chronic social defeat stress model","volume":"21","author":"Zhang","year":"2018","journal-title":"Int J Neuropsychopharmacol"},{"key":"2026092009063211600_ref157","doi-asserted-by":"publisher","first-page":"109139","DOI":"10.1016\/j.neuropharm.2022.109139","article-title":"Effects of (R)-ketamine on reduced bone mineral density in ovariectomized mice: a role of gut microbiota","volume":"213","author":"Wan","year":"2022","journal-title":"Neuropharmacology"},{"key":"2026092009063211600_ref158","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/npr2.12132","article-title":"Decreased bone mineral density in ovariectomized mice is ameliorated after subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamine","volume":"40","author":"Fujita","year":"2020","journal-title":"Neuropsychopharmacol Rep"},{"key":"2026092009063211600_ref159","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/cpt.3391","article-title":"A phase 1 assessment of the safety, tolerability, pharmacokinetics and pharmacodynamics of (2R,6R)-Hydroxynorketamine in healthy volunteers","volume":"116","author":"Raja","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"2026092009063211600_ref160","doi-asserted-by":"publisher","first-page":"111904","DOI":"10.1016\/j.bbr.2019.111904","article-title":"Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model","volume":"368","author":"Xiong","year":"2019","journal-title":"Behav Brain Res"},{"key":"2026092009063211600_ref161","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/jcb.25772","article-title":"Clinically relevant concentrations of ketamine inhibit osteoclast formation in vitro in mouse bone marrow cultures","volume":"118","author":"Du","year":"2017","journal-title":"J Cell Biochem"},{"key":"2026092009063211600_ref162","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13018-020-1579-x","article-title":"Ketamine decreases cell viability of bone explants and impairs bone healing in rats","volume":"15","author":"Horv\u00e1thy","year":"2020","journal-title":"J Orthop Surg Res"},{"key":"2026092009063211600_ref163","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s41999-021-00475-7","article-title":"Depression, antidepressants and fall risk: therapeutic dilemmas-a clinical review","volume":"12","author":"van Poelgeest","year":"2021","journal-title":"Eur Geriatr Med"},{"key":"2026092009063211600_ref164","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jagp.2013.01.008","article-title":"The complex interplay of depression and falls in older adults: a clinical review","volume":"21","author":"Iaboni","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"key":"2026092009063211600_ref165","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"key":"2026092009063211600_ref166","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician\u2019s guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int"},{"key":"2026092009063211600_ref167","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11657-022-01061-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"17","author":"Gregson","year":"2022","journal-title":"Arch Osteoporos"},{"key":"2026092009063211600_ref168","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.amjmed.2011.01.007","article-title":"Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies","volume":"124","author":"Yu","year":"2011","journal-title":"Am J Med"},{"key":"2026092009063211600_ref169","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bone.2014.04.018","article-title":"Association between use of antiepileptic drugs and fracture risk: a systematic review and meta-analysis","volume":"64","author":"Shen","year":"2014","journal-title":"Bone"},{"key":"2026092009063211600_ref170","doi-asserted-by":"publisher","first-page":"149","DOI":"10.11005\/jbm.2023.30.2.149","article-title":"Position statement: exercise guidelines for osteoporosis management and fall prevention in osteoporosis patients","volume":"30","author":"Bae","year":"2023","journal-title":"J Bone Metab"},{"key":"2026092009063211600_ref171","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00198-013-2523-2","article-title":"Too fit to fracture: exercise recommendations for individuals with osteoporosis or osteoporotic vertebral fracture","volume":"25","author":"Giangregorio","year":"2014","journal-title":"Osteoporos Int"},{"key":"2026092009063211600_ref172","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.jad.2021.09.043","article-title":"Efficacy of exercise combined with standard treatment for depression compared to standard treatment alone: a systematic review and meta-analysis of randomized controlled trials","volume":"295","author":"Lee","year":"2021","journal-title":"J Affect Disord"},{"key":"2026092009063211600_ref173","doi-asserted-by":"publisher","first-page":"e075847","DOI":"10.1136\/bmj-2023-075847","article-title":"Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials","volume":"384","author":"Noetel","year":"2024","journal-title":"BMJ"},{"key":"2026092009063211600_ref174","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pcad.2023.02.008","article-title":"Exercise as a therapeutic modality for the prevention and treatment of depression","volume":"77","author":"Blumenthal","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"key":"2026092009063211600_ref175","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2165\/00007256-200939050-00003","article-title":"Characteristics of physical activity guidelines and their effect on adherence: a review of randomized trials","volume":"39","author":"Rhodes","year":"2009","journal-title":"Sports Med"},{"key":"2026092009063211600_ref176","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1186\/s12889-024-19760-8","article-title":"The prediction model of fall risk for the elderly based on gait analysis","volume":"24","author":"Jia","year":"2024","journal-title":"BMC Public Health"},{"key":"2026092009063211600_ref177","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac205","article-title":"World guidelines for falls prevention and management for older adults: a global initiative","volume":"51","author":"Montero-Odasso","year":"2022","journal-title":"Age Ageing"},{"key":"2026092009063211600_ref178","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.euroneuro.2019.10.011","article-title":"Nutritional psychiatry: towards improving mental health by what you eat","volume":"29","author":"Adan","year":"2019","journal-title":"Eur Neuropsychopharmacol"},{"key":"2026092009063211600_ref179","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.3390\/nu12082428","article-title":"Diet, stress and mental Health","volume":"12","author":"Bremner","year":"2020","journal-title":"Nutrients"},{"key":"2026092009063211600_ref180","doi-asserted-by":"publisher","first-page":"e0168906","DOI":"10.1371\/journal.pone.0168906","article-title":"Greater intake of fruit and vegetables is associated with greater bone mineral density and lower osteoporosis risk in middle-aged and elderly adults","volume":"12","author":"Qiu","year":"2017","journal-title":"PLoS One"},{"key":"2026092009063211600_ref181","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jpsychires.2026.01.043","article-title":"Neurobiological, molecular, and systemic mechanisms of exercise in the treatment of mental health disorders","volume":"195","author":"Montgomery","year":"2026","journal-title":"J Psychiatr Res"},{"key":"2026092009063211600_ref182","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.eurpsy.2018.07.004","article-title":"EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and position statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH)","volume":"54","author":"Stubbs","year":"2018","journal-title":"Eur Psychiatry"},{"key":"2026092009063211600_ref183","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.3390\/jcm13175098","article-title":"Comparative effects of Neurodynamic slider and tensioner mobilization techniques on sympathetic nervous system function: a randomized controlled trial","volume":"13","author":"Papacharalambous","year":"2024","journal-title":"J Clin Med"},{"key":"2026092009063211600_ref184","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.3390\/jcm13175098","article-title":"Comparative effects of Neurodynamic slider and tensioner mobilization techniques on sympathetic nervous system function: a randomized controlled trial","volume":"13","author":"Papacharalambous","year":"2024","journal-title":"J Clin Med"},{"key":"2026092009063211600_ref185","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40842-018-0062-7","article-title":"The challenges of diagnosing osteoporosis and the limitations of currently available tools","volume":"4","author":"Choksi","year":"2018","journal-title":"Clin Diabetes Endocrinol"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijnp\/advance-article-pdf\/doi\/10.1093\/ijnp\/pyag044\/70709075\/pyag044.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/article-pdf\/29\/9\/pyag044\/70709075\/pyag044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/article-pdf\/29\/9\/pyag044\/70709075\/pyag044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:06:38Z","timestamp":1789909598000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/doi\/10.1093\/ijnp\/pyag044\/8766050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":185,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyag044","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,19]]},"article-number":"pyag044"}}